LBA3 Enzalutamide in men with chemotherapy-naïve metastatic castration resistant prostate cancer (MCRPC): Primary and European regional results of the phase 3 prevail study

✍ Scribed by Tombal, B.; Iversen, P.; Miller, K.; Tammela, T.; Borre, M.; Bjartell, A.; Mulders, P.; Kliment, J.; Ramon, J.; Matveev, V.; Stenzl, A.; Evans, C.P.; Sternberg, C.N.; Loriot, Y.; De Bono, J.; Carles, J.; Kim, C.S.; Kimura, G.; Noonberg, S.; Bhattacharya, S.; Perabo, F.; Phung, D.; Beer, T.M.

• Book ID: 122291248
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 153 KB
• Volume: 13
• Category: Article
• ISSN: 1569-9056
• DOI: 10.1016/S1569-9056(14)61128-3